How should a normal chromosomal microarray result (arr (X,Y)x1,(122)x2) with approximately 40% maternal cell contamination be interpreted, and what follow‑up testing is recommended?

Interpretation of Normal Chromosomal Microarray with 40% Maternal Cell Contamination

This result should be interpreted with significant caution due to the high level of maternal cell contamination, and repeat testing with a fresh sample is strongly recommended to exclude small or mosaic copy number changes and molar/partial molar conceptions that may have been obscured.

Understanding the Limitations

The 40% maternal cell contamination substantially compromises the diagnostic sensitivity of this microarray result. While the laboratory correctly notes that large copy number changes are likely still detectable, research demonstrates that:

• Small deletions become obscured at approximately 22-31% maternal contamination 1
• Small duplications are masked at 55-58% maternal contamination 1
• Sex chromosome ratio abnormalities begin showing shifts at ~10% maternal contamination 1

Your sample exceeds the threshold where small deletions would be reliably detected, meaning clinically significant microdeletion syndromes could be missed entirely.

Critical Clinical Implications

What This Result Does NOT Rule Out:

• Small copy number variants (<500 kb typically) that could cause significant genetic syndromes
• Mosaic chromosomal abnormalities where only a percentage of fetal cells carry the abnormality
• Molar or partial molar pregnancies, which have distinct management implications for maternal health
• Balanced chromosomal rearrangements (inherent limitation of all microarray testing) 2
• Point mutations in any gene

The Maternal Contamination Problem:

Studies show that maternal cell contamination in products of conception is surprisingly common—over half of "normal 46,XX" results in miscarriage specimens are actually pure maternal tissue with no embryonic component 3. In your case, while some fetal DNA is present (evidenced by the Y chromosome detection), the 40% maternal contribution creates a "dilution effect" that masks subtle fetal abnormalities.

Recommended Follow-Up Testing Algorithm

Immediate Action:

1. Obtain a fresh sample if clinically feasible and tissue remains available
2. Request repeat chromosomal microarray with explicit instruction to laboratory to minimize maternal contamination
3. Consider concurrent maternal blood sample to help distinguish maternal from fetal DNA patterns 4

If Fresh Sample Cannot Be Obtained:

For pregnancy loss/POC scenarios:

• Correlate with clinical presentation (gestational age, ultrasound findings, maternal symptoms)
• If first trimester loss: recognize that ~47% of first trimester losses have chromosomal abnormalities 5, so this "normal" result may be falsely reassuring
• If concerning for molar pregnancy (elevated hCG, ultrasound findings): strongly consider histopathologic examination as the microarray cannot reliably exclude this diagnosis with 40% contamination

For prenatal diagnosis scenarios:

• If this was from CVS or amniocentesis: repeat amniocentesis is warranted given the contamination level
• Mosaic results on CVS cannot be considered confirmatory and require amniocentesis follow-up 6

Clinical Context Matters

The interpretation depends heavily on why this testing was ordered:

• If ordered for recurrent pregnancy loss counseling: This result provides limited information about fetal chromosomal status and should not be used to definitively conclude the fetus was chromosomally normal
• If ordered for prenatal diagnosis: This level of contamination is unacceptable for clinical decision-making about pregnancy management
• If ordered to evaluate for specific syndrome: Additional targeted testing may be needed regardless

Common Pitfalls to Avoid

1. Do not assume "normal" means chromosomally normal fetus when maternal contamination is this high
2. Do not use this result alone to counsel about recurrence risk for future pregnancies
3. Do not miss molar pregnancy by relying solely on this contaminated microarray result
4. Remember that each laboratory's tolerance for maternal contamination varies based on their specific platform and analysis algorithms 1

Documentation and Counseling

When discussing with the patient:

• Explain that the test detected both fetal and maternal DNA mixed together
• The maternal DNA "drowns out" subtle fetal abnormalities
• A repeat test with better sample quality would provide more definitive information
• The presence of Y chromosome confirms some fetal tissue was present, but the high maternal contamination limits confidence in the "normal" interpretation

The bottom line: A chromosomal microarray result with 40% maternal cell contamination reported as "normal" should be considered indeterminate rather than definitively normal, and repeat testing is the standard of care when clinically indicated.